What are Investors Looking at - Research on Strategic Hotels & Resorts, Allscripts Healthcare Solutions, Kate Spade and Platform Specialty Products

ACCESSWIRE

Wed, Dec 9, 2015, 8:15 AM

NEW YORK, NY / ACCESSWIRE / December 9, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Strategic Hotels & Resorts Inc. (BEE), Allscripts Healthcare Solutions Inc. (MDRX), Kate Spade & Co. (KATE) and Platform Specialty Products Corp. (PAH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

BEE Research Package: http://www.traders-choice.com/pdf?s=BEE

MDRX Research Package: http://www.traders-choice.com/pdf?s=MDRX

KATE Research Package: http://www.traders-choice.com/pdf?s=KATE

PAH Research Package: http://www.traders-choice.com/pdf?s=PAH

============

Highlights from today's reports include:

On Tuesday, December 08, 2015, the NASDAQ Composite ended at 5,098.24, down 0.07%, the Dow Jones Industrial Average edged 0.92% lower, to finish the day at 17,568.00, and the S&P 500 closed at 2,063.59, down 0.65%.

- The stock of Strategic Hotels & Resorts Inc. gained 0.07% to close Tuesday's session at USD 14.22. The shares of the company moved in the range of USD 14.21 and USD 14.23 during the day. A trading volume of 3.83 million shares was recorded, which was lower than its 150-day daily average volume of 4.41 million shares and above its 52-week average volume of 3.53 million shares. Over the last five days, Strategic Hotels & Resorts Inc.'s shares have remained flat and in the past one month, they have gained a momentum of 0.64%. Additionally, over the last three months, the stock has advanced 1.07% and in the past six months, the shares have registered a profit of 19.60%. Further, the company is trading at a price to earnings ratio of 94.80 and the stock is at a price to book ratio of 2.41. This compares to a historical PE ratio of 20.18 and a historical PB ratio close to 2.44. Further, the stock is trading at a price to cash flow ratio of 18.42 and price to sales ratio of 2.97.

- Allscripts Healthcare Solutions Inc.'s stock decreased by 1.78% to close Tuesday's session at USD 14.92. The company's shares fluctuated in the range of USD 14.72 and USD 15.08 during the day. A total of 3.18 million shares exchanged hands, which surpassed its 50-day daily average volume of 2.75 million shares and was above its 52-week average volume of 3.00 million shares. Over the last three days Allscripts Healthcare Solutions Inc.'s shares have declined by 0.67% and in the past one week it has moved down 3.93%. However, over the last three months, the stock has gained 11.68% and in the past six months, the shares have picked up 6.80%. The stock is trading at a price to book ratio of 2.07 which compares to a historical PB ratio close to 1.79. Additionally, the stock is trading at a price to cash flow ratio of 15.72 and a price to sales ratio of 2.08.

- Kate Spade & Co.'s stock slipped by 0.42% to close Tuesday's session at USD 18.99. The company's shares oscillated between USD 18.70 and USD 19.19 in trade during the day. The stock recorded a trading volume of 2.47 million shares, which was below its 50-day daily average volume of 2.66 million shares and above its 52-week average volume of 2.09 million shares. Over the last five days, Kate Spade & Co.'s shares have declined by 6.36% and in the past one month, it has lost 11.67%. In addition, over the last three months, the stock has lost 4.28% and year to date; the shares have shed 40.67%. Further, the company is trading at a price to earnings ratio of 29.22. This compares to a historical PE ratio of 53.32. Additionally, the stock is trading at a price to sales ratio of 2.

- Platform Specialty Products Corp.'s stock declined 3.61% to close Tuesday's session at USD 10.95. The share price vacillated between USD 10.87 and USD 11.50 in trade during the day. The stock recorded a trading volume of 4.77 million shares, which was above its 50-day daily average volume of 4.65 million shares and above its 52-week average volume of 2.11 million shares. Over the last three days Platform Specialty Products Corp.'s shares have declined by 12.40% and in the past one week it has moved down 14.59%. Moreover, in the last six months, the stock has lost 60.02% and year to date; the shares have shed 52.84%. The shares of the company are trading at a price to book ratio of 1.07 and a price to sales ratio of 1.11. Additionally, the stock has a Relative Strength Index of 37.32.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
Fortune•22h ago
$433 Billion Gone! One Stock Loses More Value Than Tesla
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
Investor's Business Daily•22h ago
Analysts reset Microsoft stock price targets ahead of highly anticipated earnings
Microsoft, which overtook Apple as the world's most valuable company earlier this year, is looking to cement its AI market leadership.
TheStreet•10h ago
China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
Benzinga•13h ago
Analysts reboot Amazon stock price target ahead of earnings
This is what could happen next to Amazon shares.
TheStreet•10h ago
This Artificial Intelligence (AI) Stock Could Soar 70%, According to Wall Street. Time to Buy?
This company's exciting technology is protected by more than 100 patents.
Motley Fool•24m ago
Suze Orman Decided To Drop Homeowners Insurance After An Outrageous Quote: '$28,000 For A 2,100-Square-Foot Condo. Are You Kidding Me?'
Finance expert Suze Orman has voiced concerns about the impact of climate change on property insurance costs, asserting it could threaten the American dream of homeownership. Orman, 72, faced a $28,000 annual insurance quote for her Florida oceanside condo, leading her to forego coverage entirely. She highlights a troubling trend where soaring insurance costs driven by frequent and severe weather events may deter Americans from buying homes. Don't Miss: For many first-time buyers, a house is abo
Benzinga•2d ago
Meta stock plummets 15% after second quarter outlook disappoints
Meta reported its Q1 earnings after the bell, beating analysts' expectations on the top and bottom, but a disappointing Q2 forecast sent shares falling.
Yahoo Finance•13h ago
Intel Earnings Day Is Here. Better PC Demand Could Provide a Boost.
Intel stock bulls will need to remain patient, with multiple quarters to go before the chip company gains traction for a bet-the-company push to compete with Taiwan Semiconductor Manufacturing and Samsung in the chip-manufacturing business. Meanwhile, Intel’s first-quarter-earnings report, due after the close of trading Thursday, could show signs of improving demand from the PC segment. Citi analyst Christopher Danely, while maintaining a Neutral rating on Intel shares, recently launched an “upside catalyst watch” on the stock, which is down 32% year to date, largely due to recent disclosures of larger-than-expected losses on the company’s foundry business.
Barrons.com•2h ago
Slow, but solid US economic growth anticipated in Q1; inflation likely heats up
U.S. economic growth likely slowed to a still-solid pace in the first quarter while inflation accelerated, reinforcing financial market expectations that the Federal Reserve would delay cutting interest rates until September. The Commerce Department's snapshot of first-quarter gross domestic product on Thursday is expected to show consumers still doing the heavy lifting for the economy, thanks to a resilient labor market. The economy has defied prophecies of doom since late 2022 following the U.S. central bank's aggressive rate hiking campaign to snuff out inflation.
Reuters•6h ago

Recommended Stories